Related Experiment Video
Updated: Mar 19, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload
1Department of Toxicology and Risk Assessment, Infection Control and Environmental Health, The Norwegian Institute of Public Health, Oslo, Norway.
Abstract:
There is strong literature support for brain metal dysregulation, oxidative stress and oxidative damage to neurons in Alzheimer's disease (AD); these processes begin early and continue throughout the disease. Here, we review current knowledge on metal dysregulation and nucleic acid oxidative damage in AD (we also include new data demonstrating increased RNA and DNA oxidative damage in hippocampus from individuals having suffered from degenerative (e.g. AD) and psychological diseases: 8-oxo-7,8-dihydroguanine (8-oxoGua) levels as determined by HPLC-EC-UV were particularly elevated in RNA and heterogeneously distributed among adjacent regions versus the control). Whereas neuronal iron accumulation occurs in aging, neuronal iron levels further increase in AD accompanied by oxidative damage, decreased copper levels, amyloid plaque formation and brain inflammation. The 'hepcidin-ferroportin iron overload' AD hypothesis links these processes together and is discussed here. Moreover, we find that most existing transgenic animal AD models only partly involve these processes, rather they are often limited to expression of mutated amyloid beta protein precursor (AbetaPP), presenilin, tau or apolipoprotein E proteins although a few models appear more relevant than others. Relevant models are likely to be crucial for refining and testing this hypothesis as well as developing new drugs.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
